News
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
By: investing_za
- Dec 18 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS